NDC 10631-332

Ximino

Minocycline Hydrochloride

Ximino is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc. The primary component is Minocycline Hydrochloride.

Product ID10631-332_c87b3360-adb8-444e-9591-52d2b97b8e08
NDC10631-332
Product TypeHuman Prescription Drug
Proprietary NameXimino
Generic NameMinocycline Hydrochloride
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2017-10-25
Marketing CategoryNDA / NDA
Application NumberNDA201922
Labeler NameSun Pharmaceutical Industries, Inc
Substance NameMINOCYCLINE HYDROCHLORIDE
Active Ingredient Strength135 mg/1
Pharm ClassesTetracycline-class Drug [EPC],Tetracyclines [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 10631-332-05

500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-332-05)
Marketing Start Date2017-10-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10631-332-69 [10631033269]

Ximino CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA201922
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-10-25
Inactivation Date2020-01-31

NDC 10631-332-30 [10631033230]

Ximino CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA201922
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-10-25
Inactivation Date2020-01-31

NDC 10631-332-06 [10631033206]

Ximino CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA201922
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-10-25
Marketing End Date2018-08-17

NDC 10631-332-05 [10631033205]

Ximino CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA201922
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-10-25
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
MINOCYCLINE HYDROCHLORIDE135 mg/1

OpenFDA Data

SPL SET ID:6e7d2a2f-e4b2-4d12-8d5d-e1c3a832b35c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1302664
  • 1302666
  • 1302676
  • 1302674
  • 1302650
  • 1302656
    • UPC Code
  • 0310631331306
  • 0310631330309
  • 0310631332303

    • Pharmacological Class

    • Tetracycline-class Drug [EPC]
    • Tetracyclines [CS]

    NDC Crossover Matching brand name "Ximino" or generic name "Minocycline Hydrochloride"

    NDCBrand NameGeneric Name
    10631-330Ximinominocycline hydrochloride
    10631-331Ximinominocycline hydrochloride
    10631-332Ximinominocycline hydrochloride
    69489-121XiminoXimino
    69489-122XiminoXimino
    69489-123XiminoXimino
    0093-2133Minocycline HydrochlorideMinocycline Hydrochloride
    0093-2134Minocycline HydrochlorideMinocycline Hydrochloride
    0093-7741Minocycline HydrochlorideMinocycline Hydrochloride
    0093-7742Minocycline HydrochlorideMinocycline Hydrochloride
    0093-7743Minocycline HydrochlorideMinocycline Hydrochloride
    0115-9935minocycline hydrochlorideminocycline hydrochloride
    0115-9936minocycline hydrochlorideminocycline hydrochloride
    0378-4293Minocycline Hydrochlorideminocycline hydrochloride
    0378-4294Minocycline Hydrochlorideminocycline hydrochloride
    0440-7805Minocycline hydrochlorideMinocycline hydrochloride
    0591-3153Minocycline HydrochlorideMinocycline Hydrochloride
    0591-5694Minocycline HydrochlorideMinocycline Hydrochloride
    0591-5695Minocycline HydrochlorideMinocycline Hydrochloride
    0781-5385Minocycline HydrochlorideMinocycline Hydrochloride
    0781-5386Minocycline HydrochlorideMinocycline Hydrochloride
    0781-5387Minocycline HydrochlorideMinocycline Hydrochloride
    0904-6888Minocycline HydrochlorideMinocycline Hydrochloride
    13668-482Minocycline HydrochlorideMinocycline Hydrochloride

    Trademark Results [Ximino]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    XIMINO
    XIMINO
    86210940 5370300 Live/Registered
    SUN PHARMACEUTICAL INDUSTRIES, INC.
    2014-03-04
    XIMINO
    XIMINO
    85069814 not registered Dead/Abandoned
    RANBAXY LABORATORIES LIMITED
    2010-06-23
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.